Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FOXO TechnologiesFOXO +31.81%18 12-1 Month Momentum % is -99.84% as of Sep. 11, 2026. GuruFocus rates FOXO with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 653 Healthcare Providers & Services companies, FOXO Technologies ranks worse than 99.69% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-11), FOXO Technologies's 12-1 Month Momentum % is -99.84%.
The industry rank for FOXO Technologies's 12-1 Month Momentum % or its related term are showing as below:
FOXO's 12-1 Month Momentum % is ranked worse than 99.69% of 653
companies
in the Healthcare Providers & Services industry
Industry Median: -13.08
vs FOXO: -99.84
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
FOXO Technologies 12-1 Month Momentum % Related Terms
FOXO vs FCHS, BACK, GRST: 12-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, FOXO Technologies's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FOXO Technologies 12-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, FOXO Technologies's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where FOXO Technologies's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -99.84% mean?
FOXO Technologies (FOXO) has a 12-1 Month Momentum % of -99.84% as of Sep. 11, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on FOXO Technologies and its competitors. According to the industry distribution chart, FOXO Technologies ranks #651 out of 653 companies in the Healthcare Providers & Services industry, placing it in the top 99.7%.
Is FOXO Technologies' 12-1 Month Momentum % too high?
FOXO Technologies' current 12-1 Month Momentum % is -99.84%. Based on the distribution chart, FOXO Technologies ranks #651 out of 653 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, FOXO Technologies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does FOXO Technologies' 12-1 Month Momentum % compare to FCHS and BACK?
According to the Healthcare Providers & Services industry distribution chart, FOXO Technologies ranks #651 out of 653 companies for 12-1 Month Momentum %. This places FOXO Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Providers & Services company?
A good 12-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on FOXO Technologies and its competitors. FOXO Technologies's current 12-1 Month Momentum % is -99.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FOXO Technologies stock overvalued right now?
FOXO Technologies (FOXO) has a current 12-1 Month Momentum % of -99.84%. The current 12-1 Month Momentum % is -99.84%. FOXO Technologies' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For FOXO Technologies (FOXO), the current 12-1 Month Momentum % is -99.84% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.
18GF Score
Get the complete analysis for FOXO
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FOXO has been successfully added to your 
